Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Daily News

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Yael L. Maxwell

December 17, 2024

News Daily News

Female-Specific Factors Don’t Enhance Common Risk Calculators

Caitlin E. Cox

December 10, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

Presentation TCT 2024

PE is a R Heart Disease: How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

Presenter: Sanjum Sethi

October 30, 2024

Presentation TCT 2024

How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

Presenter: Daniel Burkhoff

October 30, 2024

Presentation TCT 2024

TCT 264: Improving Risk Stratification of SCAI Stages of Cardiogenic Shock With Machine Learning-Based Phenotyping

Presenter: Elric Zweck

October 29, 2024

Presentation TCT 2024

What Next After Establishing the Diagnosis: Risk Stratification for Acute PE

Presenter: Amir Darki

October 29, 2024

Presentation TCT 2024

Post-TAVR Risk-Stratification for Conduction Disturbances

Presenter: Shmuel Chen

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

TCT 173: Contemporary Risk Prediction and Stratification of Long-Term Major Adverse Cardiac and Cerebrovascular Events After Percutaneous Coronary Intervention: The REMEDY Score

Presenter: Jiaxi Cheng

October 28, 2024

Presentation TCT 2024

TCT 357: Risk Stratification of Thrombosis in Coronary Artery Aneurysms and Ectasia

Presenter: Brennan Vogl

October 27, 2024

News Daily News

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Caitlin E. Cox

October 24, 2024

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Caitlin E. Cox

October 08, 2024

News Daily News

AI-Measured Breast Artery Calcification Tied to CV Outcomes in Women

Todd Neale

October 07, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Conference News ESC 2024

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Caitlin E. Cox

September 12, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Yael L. Maxwell

August 08, 2024

Advertisement

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Female-Specific Factors Don’t Enhance Common Risk Calculators

November 2024 Dispatch for the CV Team

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

PE is a R Heart Disease: How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

TCT 264: Improving Risk Stratification of SCAI Stages of Cardiogenic Shock With Machine Learning-Based Phenotyping

What Next After Establishing the Diagnosis: Risk Stratification for Acute PE

Post-TAVR Risk-Stratification for Conduction Disturbances

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

TCT 173: Contemporary Risk Prediction and Stratification of Long-Term Major Adverse Cardiac and Cerebrovascular Events After Percutaneous Coronary Intervention: The REMEDY Score

TCT 357: Risk Stratification of Thrombosis in Coronary Artery Aneurysms and Ectasia

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

AI-Measured Breast Artery Calcification Tied to CV Outcomes in Women

Little Pre- and Postmarket Testing for Most Recalled CV Devices

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Scientific Statement Reviews Current Antithrombotic Options in PAD

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content